p21Cip1 protection against hyperoxia requires Bcl-XL and is uncoupled from its ability to suppress growth

American Journal of Pathology

Volumn 168, Issue 6, 2006, Pages 1838-1847

  Vitiello, Peter F ^a   Staversky, Rhonda J ^b   Gehen, Sean C ^a   Johnston, Carl J ^b   Finkelstein, Jacob N ^b   Wright, Terry W ^b   O'Reilly, Michael A ^b  

^a UNIVERSITY OF ROCHESTER   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1; PROTEIN BCL 2; PROTEIN BCL XL; CDKN1A PROTEIN, HUMAN; CDKN1A PROTEIN, MOUSE; CDKN1A PROTEIN, RAT; CYCLIN DEPENDENT KINASE INHIBITOR 1A; PROTEIN BCL X;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CELL DEATH; CELL PROLIFERATION; CELL PROTECTION; CELL SURVIVAL; CONTROLLED STUDY; GROWTH INHIBITION; HUMAN; HUMAN CELL; HYPEROXIA; IMMUNOHISTOCHEMISTRY; INTERNAL RIBOSOME ENTRY SITE; MOUSE; MULTIGENE FAMILY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RIBONUCLEASE PROTECTION ASSAY; RNA INTERFERENCE; STATISTICAL ANALYSIS; WESTERN BLOTTING; ANIMAL; ANOXIA; C57BL MOUSE; CELL LINE; METABOLISM; PHYSIOLOGY; RAT; TRANSGENIC MOUSE; TUMOR CELL LINE;

ANIMALS; ANOXIA; BCL-X PROTEIN; CELL LINE; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; HUMANS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; RATS;

EID: 33744739882     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2006.051162     Document Type: Article

References (44)

1. Jenkinson SG: Oxygen toxicity. New Horiz 1993, 1:504-511
2. Crapo JD, Barry BE, Foscue HA, Shelburne J: Structural and biochemical changes in rat lungs occurring during exposures to lethal and adaptive doses of oxygen. Am Rev Respir Dis 1980, 122:123-143
3. Barazzone C, Horowitz S, Donati YR, Rodriguez I, Piguet PF: Oxygen toxicity in mouse lung: pathways to cell death. Am J Respir Cell Mol Biol 1998, 19:573-581
4. Quinlan T, Spivack S, Mossman BT: Regulation of antioxidant enzymes in lung after oxidant injury. Environ Health Perspect 1994, 102(Suppl 2):79-87
5. McGrath-Morrow SA, Cho C, Soutiere S, Mitzner W, Tuder R: The effect of neonatal hyperoxia on the lung of p21Waf1/Cip1/Sdi1-deficient mice. Am J Respir Cell Mol Biol 2004, 30:635-640
6. O'Reilly MA, Staversky RJ, Watkins RH, Maniscalco WM, Keng PC: p53-independent induction of GADD45 and GADD153 in mouse lungs exposed to hyperoxia. Am J Physiol Lung Cell Mol Physiol 2000, 278:L552-L559
7. O'Reilly MA, Staversky RJ, Watkins RH, Maniscalco WM: Accumulation of p21(Cip1/WAF1) during hyperoxic lung injury in mice. Am J Respir Cell Mol Biol 1998, 19:777-785
8. O'Reilly MA, Staversky RJ, Huyck HL, Watkins RH, LoMonaco MB, D'Angio CT, Baggs RB, Maniscalco WM, Pryhuber GS: Bcl-2 family gene expression during severe hyperoxia induced lung injury. Lab Invest 2000, 80:1845-1854
9. O'Reilly MA, Staversky RJ, Watkins RH, Reed CK, de Mesy Jensen KL, Finkelstein JN, Keng PC: The cyclin-dependent kinase inhibitor p21 protects the lung from oxidative stress. Am J Respir Cell Mol Biol 2001, 24:703-710
10. Helt CE, Rancourt RC, Staversky RJ, O'Reilly MA: p53-dependent induction of p21 Cip1/Waf1/Sdi1 protects against oxygen-induced toxicity. Toxicol Sci 2001, 63:214-222
11. Luo Y, Hurwitz J, Massague J: Cell-cycle inhibition by independent CDK and PCNA binding domains in p21Cip1. Nature 1995, 375:159-161
12. Rousseau D, Cannella D, Boulaire J, Fitzgerald P, Fotedar A, Fotedar R: Growth inhibition by CDK-cyclin and PCNA binding domains of p21 occurs by distinct mechanisms and is regulated by ubiquitin-proteasome pathway. Oncogene 1999, 18:4313-4325
13. Corroyer S, Maitre B, Cazals V, Clement A: Altered regulation of G1 cyclins in oxidant-induced growth arrest of lung alveolar epithelial cells: accumulation of inactive cyclin E-DCK2 complexes. J Biol Chem 1996, 271:25117-25125
14. Rancourt RC, Keng PC, Helt CE, O'Reilly MA: The role of p21 Cip1/WAF1 in growth of epithelial cells exposed to hyperoxia. Am J Physiol 2001, 280:L617-L626
15. Helt CE, Staversky RJ, Lee YJ, Bambara RA, Keng PC, O'Reilly MA: The CDK and PCNA domains on p21 Cip1 both function to inhibit G1/S progression during hyperoxia. Am J Physiol Lung Cell Mol Physiol 2004, 286:L506-L513
16. Kauffman SL, Burri PH, Weibel ER: The postnatal growth of the rat lung: II. Autoradiography. Anat Rec 1974, 180:63-76
17. Wang X, Ryter SW, Dai C, Tang ZL, Watkins SC, Yin XM, Song R, Choi AM: Necrotic cell death in response to oxidant stress involves the activation of the apoptogenic caspase-8/bid pathway. J Biol Chem 2003, 278:29184-29191
18. Budinger GR, Tso M, McClintock DS, Dean DA, Sznajder JI, Chandel NS: Hyperoxia-induced apoptosis does not require mitochondrial reactive oxygen species and is regulated by Bcl-2 proteins. J Biol Chem 2002, 277:15654-15660
19. Buccellato LJ, Tso M, Akinci OI, Chandel NS, Budinger GR: Reactive oxygen species are required for hyperoxia-induced Bax activation and cell death in alveolar epithelial cells. J Biol Chem 2004, 279:6753-6760
20. Ward NS, Waxman AB, Homer RJ, Mantell LL, Einarsson O, Du Y, Elias JA: Interleukin-6-induced protection in hyperoxic acute lung injury. Am J Respir Cell Mol Biol 2000, 22:535-542
21. He CH, Waxman AB, Lee CG, Link H, Rabach ME, Ma B, Chen Q, Zhu Z, Zhong M, Nakayama K, Nakayama KI, Homer R, Elias JA: Bcl-2-related protein A1 is an endogenous and cytokine-stimulated mediator of cytoprotection in hyperoxic acute lung injury. J Clin Invest 2005, 115:1039-1048
22. Gorospe M, Cirielli C, Wang X, Seth P, Capogrossi MC, Holbrook NJ: p21(Waf1/Cip1) protects against p53-mediated apoptosis of human melanoma cells. Oncogene 1997, 14:929-935
23. Yin Y, Solomon G, Deng C, Barrett JC: Differential regulation of p21 by p53 and Rb in cellular response to oxidative stress. Mol Carcinog 1999, 24:15-24
24. Javelaud D, Besancon F: Inactivation of p21WAF1 sensitizes cells to apoptosis via an increase of both p14ARF and p53 levels and an alteration of the Bax/Bcl-2 ratio. J Biol Chem 2002, 277:37949-37954
25. Yu J, Wang Z, Kinzler KW, Vogelstein B, Zhang L: PUMA mediates the apoptotic response to p53 in colorectal cancer cells. Proc Natl Acad Sci USA 2003, 100:1931-1936
26. O'Reilly MA, Staversky RJ, Watkins RH, Reed CK, de Mesy Jensen KL, Finkelstein JN, Keng PC: The cyclin-dependent kinase inhibitor p21 protects the lung from oxidative stress. Am J Respir Cell Mol Biol 2001, 24:703-710
27. Wright TW, Gigliotti F, Finkelstein JN, McBride JT, An CL, Harmsen AG: Immune-mediated inflammation directly impairs pulmonary function, contributing to the pathogenesis of Pneumocystis carinii pneumonia. J Clin Invest 1999, 104:1307-1317
28. Helt CE, Rancourt RC, Staversky RJ, O'Reilly MA: p53-dependent induction of p21(Cip1/WAF1/Sdi1) protects against oxygen-induced toxicity. Toxicol Sci 2001, 63:214-222
29. Helt CE, Staversky RJ, Lee YJ, Bambara RA, Keng PC, O'Reilly MA: The Cdk and PCNA domains on p21Cip1 both function to inhibit G1/S progression during hyperoxia. Am J Physiol Lung Cell Mol Physiol 2004, 286:L506-L513
30. Engel FB, Hauck L, Boehm M, Nabel EG, Dietz R, von Harsdorf R: p21(CIP1) controls proliferating cell nuclear antigen level in adult cardiomyocytes. Mol Cell Biol 2003, 23:555-565
31. Deng C, Zhang P, Harper JW, Elledge SJ, Leder P: Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 1995, 82:675-684
32. Waldman T, Lengauer C, Kinzler KW, Vogelstein B: Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21. Nature 1996, 381:713-716
33. Bartek J, Lukas C, Lukas J: Checking on DNA damage in S phase. Nat Rev Mol Cell Biol 2004, 5:792-804
34. Polyak K, Waldman T, He TC, Kinzler KW, Vogelstein B: Genetic determinants of p53-induced apoptosis and growth arrest. Genes Dev 1996, 10:1945-1952
35. Hainaut P, Milner J: Redox modulation of p53 conformation and sequence-specific DNA binding in vitro. Cancer Res 1993, 53:4469-4473
36. Allan LA, Duhig T, Read M, Fried M: The p21(WAF1/CIP1) promoter is methylated in Rat-1 cells: stable restoration of p53-dependent p21(WAF1/CIP1) expression after transfection of a genomic clone containing the p21(WAF1/CIP1) gene. Mol Cell Biol 2000, 20:1291-1298
37. Wagner KU, Claudio E, Rucker EB III, Riedlinger G, Broussard C, Schwartzberg PL, Siebenlist U, Hennighausen L: Conditional deletion of the Bcl-x gene from erythroid cells results in hemolytic anemia and profound splenomegaly. Development 2000, 127:4949-4958
38. Rucker EB III, Dierisseau P, Wagner KU, Garrett L, Wynshaw-Boris A, Flaws JA, Hennighausen L: Bcl-x and Bax regulate mouse primordial germ cell survival and apoptosis during embryogenesis. Mol Endocrinol 2000, 14:1038-1052
39. Shiraiwa N, Inohara N, Okada S, Yuzaki M, Shoji S, Ohta S: An additional form of rat Bcl-x, Bcl-xbeta, generated by an unspliced RNA, promotes apoptosis in promyeloid cells. J Biol Chem 1996, 271:13258-13265
40. Yang XF, Weber GF, Cantor H: A novel Bcl-x isoform connected to the T cell receptor regulates apoptosis in T cells. Immunity 1997, 7:629-639
41. Pecci A, Viegas LR, Baranao JL, Beato M: Promoter choice influences alternative splicing and determines the balance of isoforms expressed from the mouse bcl-X gene. J Biol Chem 2001, 276:21062-21069
42. Viegas LR, Vicent GP, Baranao JL, Beato M, Pecci A: Steroid hormones induce bcl-X gene expression through direct activation of distal promoter P4. J Biol Chem 2004, 279:9831-9839
43. Grad JM, Zeng XR, Boise LH: Regulation of Bcl-xL: a little bit of this and a little bit of STAT. Curr Opin Oncol 2000, 12:543-549
44. Fritah A, Saucier C, Mester J, Redeuilh G, Sabbah M: p21WAF1/CIP1 selectively controls the transcriptional activity of estrogen receptor [alpha]. Mol Cell Biol 2005, 25:2419-2430